Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Fresenius Medical Care Q3 2026 Results: Net Income $225M, Down 31.3% YoY

Fresenius Medical Care AG reported its interim financial results for the third quarter of 2026, highlighting a reorganization of its pharmaceutical business from the Care Enablement segment to the Care Delivery segment. The report also notes the integration of administrative functions for the Value-Based Care segment into global functional areas and the ongoing implementation of a new enterprise resource planning software.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Net income224.8327.3

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Net income, year on year-31.3%
Source

6-K filed with the SEC, NYSE: FMS. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Fresenius Medical Care AG: key numbers

Share price
$21.69Close, Nov 17
Sector
Industrial Applications and Services
Industry
Services-Misc Health & Allied Services, NECSIC 8090

Today's reference numbers, updated daily. Not a valuation or a recommendation.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.